SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HEPS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021 Pharmaceutical Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of APPH, BMY, EAR and HNST Pharmaceutical Investing
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021 Pharmaceutical Investing
Allergan, an AbbVie Company, to Present New Data on Investigational AGN-190584 for the Treatment of Presbyopia Pharmaceutical Investing
Wellteq Digital Health Inc. Partners With Top Global University to Commercialise Sleep Research Company News
Aptose to Report Third Quarter 2021 Financial Results and Hold Conference Call on Thursday, November 11, 2021 Market News
